← Leaderboards
Jenny Leigh Newlon
Empowerx, Inc.
$851,003
Attributed
$2,431,595
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$2,188,768 · 2
NIH$242,827 · 1
By mechanism
R44$2,188,095 · 2
R43$243,500 · 1
Top collaborators
- Sally Rafie4 shared
- Ashley H Meredith3 shared
Most similar at Empowerx, Inc.
Same institution · by research overlap
- Sally Rafie$851,003
- Ashley H Meredith$729,589
Others in their field
Other Emerging Leaders on “Adherence”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Martha Hering · Westat, Inc.$57,098,843
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Susan M Landau · University Of California Berkeley$47,252,026
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
- Priyamvada Acharya · Duke University$20,941,151
Research focus
AdherenceAdoptionAreaAwardAwarenessBusinessesCare CoordinationCenters For Disease Control And Prevention (U.S.)Clinical TrialsCommercializationCommunitiesCommunity Based Participatory ApproachCommunity Based Participatory ResearchCommunity EngagementCommunity OrganizationsCommunity PartnersCommunity PharmacyComputer SoftwareConsumptionContinuity Of Patient CareContraceptive AgentsData CollectionDesignAcquired Immunodeficiency Syndrome
Grant awards (4)
Hormonal contraceptive Access via Pharmacist-Prescribing Implementation package (HAPPI)$930,624
R44 · FY2025 · DP
PEP/PrEP via Pharmacist-Prescribing Implementation (PEPPI)$242,827
R44 · FY2025 · MH
Hormonal contraceptive Access via Pharmacist-Prescribing Implementation package (HAPPI)$1,014,644
R44 · FY2024 · DP
Hormonal contraceptive Access via Pharmacist-Prescribing Implementation package (HAPPI)$243,500
R43 · FY2021 · DP · contact PI